GlassScriptPhysician profile
Hakan M Kutlu
NPI 1164497301
$1,562.41
in general payments reported to CMS, 2019-2025
26 companies · $241 in 2025
The $241 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $241 · 2021: $132 · 2022: $130 · 2023: $372 · 2024: $247 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $860.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $343.59 | 2019-2022 | |
| Kci USA, INC. | $157.50 | 2019-2023 | Prevena |
| Acera Surgical, INC. | $143.61 | 2022-2025 | Restrata Wound Matrix |
| Biotronik Nro, INC. | $109.38 | 2024 | Prospera |
| Mentor Worldwide LLC | $97.72 | 2022-2023 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Smith+Nephew, INC. | $72.87 | 2021-2024 | Collagenase Santyl |
| Djo, LLC | $54.89 | 2023 | Cmf |
| Collegium Pharmaceutical, INC. | $54.76 | 2023-2024 | Xtampza, Belbuca |
| Sanara Medtech INC. | $53.27 | 2025 | Celleraterx |
| Spr Therapeutics, INC | $47.16 | 2025 | Sprint Pns System |
| Merz North America, INC. | $46.52 | 2021 | |
| Becton, Dickinson and Company | $38.73 | 2024 | Channel Drain |
| Integra Lifesciences Corporation | $37.34 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Xtant Medical INC | $35.35 | 2023 | |
| Abbvie INC. | $34.61 | 2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.61 | 2023 | Relistor |
| Kowa Pharmaceuticals America, INC. | $26.80 | 2022 | |
| Solventum Corporation | $25.04 | 2025 | Prevena |
| Tela Bio, INC. | $24.70 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kerecis Limited | $22.98 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Davol INC. | $20.70 | 2019 | |
| Mimedx Group, INC. | $19.75 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $17.67 | 2025 | |
| Scilex Pharmaceuticals INC. | $17.00 | 2023 | Ztlido |
| Partner Therapeutics, INC. | $15.44 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hakan Kutlu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.